Clinical trial

Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by…

NCT00006094 · National Cancer Institute (NCI), NIH · Completed

Key facts

NCT number NCT00006094
Title Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum
Official title A Phase I/II Study of Preoperative Oxaliplatin (NSC# 266046), 5-Fluorouracil, and External Beam Radiation Therapy in Locally Advanced Rectal Cancer
Lead sponsor National Cancer Institute (NCI), NIH
Status Completed
Phase Phase 1/Phase 2
Study type Interventional
Conditions Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
Intervention type Drug, Radiation
Interventions oxaliplatin, fluorouracil, external beam radiation therapy
Enrollment 24
Start date Jul 1, 2000
Primary completion Oct 1, 2006
First posted Jan 27, 2003
Last update posted Jan 16, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies